Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin for Beta Cell Function in T2DM
NCT02097342Phase 4Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Dec 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02097342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097342.